Kejadian Keloid Menurut Golongan Darah Pada Pasien Pasca Luka Di RSUP H.Adam Malik Medan
KEPUSTAKAAN
Moustafa, MF, Abdel-fattah, MA & Abdel-fattah, DC 1975,”Presumptive evidence of the
effect of pregnancy estrogens on keloid growth”, case report : Plast Reconstr Surg, vol. 56,
pp. 450-453
Mast, BA 1992,”Wound healing : Biochemical and clinical aspect in the skin”,ed IK cohen, B
Diegelmann & WJ and Lindblad WB, Saunder Company, Philadelphia,pp. 344
Nemeth, AJ 1993,”Keloid and hypertropic scars”, J Dermatol Surg Oncol, vol. 19, no. 8, pp.
738-746
Prockop, DJ & Kivirikko, KI 1995,”Collagens : molecular biology, disease, and potentials
for therapy”, Ann Rev Biochem, vol.64. pp. 403-434
Raghaw, R 1994,”The role of etracellular matrix in post imflammatory wound healing and
fibrosis”, FASEB J, vol. 8, no. 11, pp. 823-831
Santoro, MM & Gaudino, G 2005,”Cellular and molecular facets of keratinocytte
reepithelizzation during wound healing”, Exp Cell Res, vol. 304, no. 1, pp. 274-286
Schierle, HP, Scholz, D & Lemperle, G 1997,”Elevated levels of testosteron reseptors in
keloid tissue: an experimental investigation”, Plast Recontr Surg, vol.100, no. 2, pp. 390-395,
discussion 396
Sukla, IM, Arora, NP & Arora, MM 1975,”Corneal keloid”, Indian J Opthalmol, vol. 23,n0.
2, pp. 18-19
Slemp, AE & Kirsner, RE 2006,”Keloid and scars : a review of keloid and scars, their
patthogenesis, risk factors, and management”, Curr Opin Pediatr, vol. 18, no. 4, pp. 396-402
Stadelmann, WK, Digenis, AG & Tobin, GR 1998,”Physiology and healing dynamics of
chronic cuttaneus wound”, Am J Surg, vol. 176, no. 2A Suppl, pp. 26S-28S
Universitas Sumatera Utara
Sylvia, CJ 2003,”The role of neutrophil apoptosis in influencing tissue repair”, J Wound Care
, vol.12, no.1, pp. 13-16
Werner, S & Grose, R 2003,”Regulation of wound healing by growth factors and cytokine”,
Physiol Rev,vol. 83, no. 3, pp. 835-870
Urioste, SS, Arndt, KA & Dover, JS 1999,”Keloids and hypertropic scars : revieww and
treatment strategies”, Semin Cutan Med Surg, vol. 211, no. 2, pp. 159-171
Ong, CT, Khoo, YT, Tan, EK 2007,”Epithelial - mesenchimal interactions in keloid
pathogenesis modulate vascular endothelial growth factors expression and secretion”, J
Pathol, vol. 211, no. 1, pp. 95-108
Louw, L 2007,”The keloid phenomenon : progres toward a solution”, Clin Anat, vol.20, no.
1,, pp. 3-14
Knigton, DR, Hunt, TK 1983,”Oxygen tension regulated the expression of angiogenesis
factors by macrophages”, Science, vol. 221, no. 4617, pp. 1283-1285
Hinz, B 2006,”Masters and servants of the force : the role of matrix adhesions in
myofibroblast force perception and transmission’’, Eur J Cell Biol, vol. 9, no. 3-4, pp. 175181
Ford, LC, King, DF, Lagasse, LD & Newcomer, V 1983,”Increased androgen binding in
keloids : a preliminary communication”, J Dermatol Surg Oncol, vol. 9, no. 7, pp. 545-547
Cheng, JC, Evans, JH, Leung, KS 1984,”Pressure therapy in the treatment of post burn
hypertrophic scars”, Burn Ince Therm Inj. vol. 10, no. 3, pp. 154-163
Bloom, D 1956,”Heredity of keloids : review of the literature and report of a family with
multiple keloids in five generation”, N Y State J Med,vol.56, no. 4, pp. 511-519
Apfelberg, DB, Maser, MR, White, DN & Lash, H 1989,”Failure of carbon dioxide laser
excission of keloids”, Laser Surg Med, vol. 9, no. 4, pp. 382-388
Universitas Sumatera Utara
Appleton, I, Brown, NJ & Willoghby, DA 1996,”Apoptosis, necrosis, and proliferation :
possible implication in the etiology of keloids”, Am J Pathol, vol. 149, no. 5, pp. 1441-1447
Toure, Abas M. Is There an Association between Keloids and Blood Groups. Available in:
ISRDN Dermatology Vol 2012. 2012
Hilmer MP, Macleod SM, 2002. Experimental
keloid
scar
models: A review of
methodological issues journal. Journal of Cutaneous Medicine and Surgery 6(4).
Perdanakusuma D, Gayatri K. P. 2009. The relationship between blood type and the
formation of keloid post wound. Departemen / SMF Ilmu Bedah Plastik Fakultas Kedokteran
Universitas Airlangga, RSUD Dr. Soetomo, Surabaya.
Kischer CW, 1982. Fibronectin (FN) in hypertrophic scars and keloid. Cell and Tissue
Research 23 1(I): 29-37.
Savage K, Swann DA, 1985. A comparison of glycosaminoglycan synthesis by human
fibroblasts from normal skin, normal scar, and hypertropic scar. Journal Invest Dermatology
34(6) : 521-6.
Wolfram D,
Alexandar T.
Hypertrophic Scars and Keloids – A review of Their
Pathophysiology, Risk Factors, and Therapeutic Management. Available in: Dermatol Surg
2009; 35. 2009; 171-181
Ajab K., Shahzad M, Haroon T S. Keloids: Clinical Features and Management Part I.
Available in: Journal of Pakistan Association of Dermatologists 2006; 16: 97-103
Melinda S, Meites E, Daane SP. Keloids: Which Treatment is best for your patient?.
Available in: The Journal of Family Practice Vol 62 No 5. 2013: 227-233
Gauglitz Gerd G. Hypertrophic Scarring and Keloids: Pathomecanisms and Current and
Emerging Treatment Strategies. Available in: Mol Med 17 (1-2). 2011: 113-125
Universitas Sumatera Utara
Al-Attar A, Mess S, Thomassen JM . Keloid Pathogenesis and Treatment. Available in:
Plastic Reconstruction Surgery 117:286. 2006: 286-300
Seifert Oliver., Mrowietz Ulrich. Keloid Scarring: bench and bedside. Available in: Arch
Dermatol Res (2009) 301:259-272
Perdanakusuma DS, Noer MS, 2006. Penanganan parut hipertrofik dan keloid. Surabaya:
Airlangga University Press, pp. 4-18
Al-Attar, A, Mess, S, Thomassen, JM, Kauffman, CL & Davison, SP
2006, 'Keloid
pathogenesis and treatment', Plast Reconstr Surg, vol. 117, no. 1, pp. 286-300.
Sudigdo,F,Sofyan,I, 2008, Dasar – dasar metodologi penelitian klinis,ed. III. Sagung seto.
Gentur,S, 2011, Petunjuk praktis ilmu bedah plastik rekonstruksi, yayasan
khasanah
kebajikan. Sagung seto.
J. J. Brown and A. Bayat , ”Genetics susceptibility to raised dermal scarring,” British Journal
of Dermatology,vol.161, no.I, pp. 8-18,2004.
B. Shih and A. Bayat, “Genetic of keloid scarring,” Archives of Dermatological
Research,vol. 302,no. 5, pp. 319-339,2014.
A.G. Marneros, J. E. C. Norris,S. Watanabe,E. Reichenberger, and B. R. Olsen, “Genome
scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11,”
Journal of Investigative Dermatology,vol. 122,no. 5, pp. 1126-1132,2004.
J. A. Clark,M. L. Turner,L. Howard,H. Stanescu,R. Kleta, and J. B. Kopp,”Description of
familial keloids in five pedigrees: evidence for autosomal dominant inheritance and
phenotypic heterogeneity,” BMC Dermatology, vol. 9, article 8, 2001.
K. M. Ramakrishnan, K. P. Thomas, and C. R. Sundararajan, “Study of 1,000 patients with
keloids in South India,,” Plastic and Reconstructive Surgery, vol. 53, no. 3, pp. 276-280,
1974.
Universitas Sumatera Utara
R. S. English and P. D. Shenefelt, “Keloid and hypertrophic scars,” Dermatologic Surgery,
vol. 25, no. 8, pp. 631-638, 1999.
Ishihara H, Yoshimoto H, Fujioka M (2000)
Keloid fibroblast resist ceramide-induced
apoptosis by overexxpression of insulin-like growth factor I receptor. J Invest Dermatol 115:
10655-1071.
Sayah DN, Soo C, Shaw WW (1999) Downregulation of apoptosis-related genes in keloid
tissues. J Surg Res 87 :209-216
Ghazizadeh M (2007) Essential role of IL-6 signaling pathway in keloid pathogenesis. J
Nippon Med Sch 7:11-22
Messadi DV, Doung HS, Zhang Q (2004) Activation of NfkappaB signal pathwayys in
keloid fibroblats. Arch Dermatol Res 296:125-133
Santucci M, Borbognoni L, Reali UM (2001) Keloids and hypertrophic scars of Caucasians
show distinctive morphologic and immunophenotypic profiles. Virchowws Arch 438:457463
Niessen FB, Schalkwwijk J, Vos H (2004) Hypertrophic scar formation is associated wwith
an increased number of epidermal Langerhans cells. J Pathol 202:121-129
Tuan TL, Wu H, Huang EY (2003) Increased plasminogen activator inhibitor-1 in keloid
fibroblast may account for their elevated collagen accumulation in fibrin gel cultures. Am J
Pathol 162:1579-1585
Zhang Q, Wu Y, Ann DK
(2003) Mechanisms of hypoxic regulation of plasminogen
activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 121:1005-1012
Universitas Sumatera Utara
Wu Y, Zhang Q, Ann DK (2004) Increased vascular endothelial growth factor may account
for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid
fibroblasts. Am J Physiol Cell Physiol 286:C905-C912
Chodon T, Sugihara T, Igawa HH (2000) Keloid-derived fibroblasts are refractory to Fasmediated apoptosis and neutralizzation of autocrine transforming growth factor-beta I can
abrogate this resiostance. Am J Pathol 157:1661-1669
Funayama E, Chodon T, Oyama (2003) Keratinocytes promote proliferation and inhibit
apoptosis of the underlying fibroblasts: an important role in tthe pathogenesis of keloid. J
Invest Dermatol 121:1326-1333
Lim IJ, Phan TT, Song C
(2001) Investigation of the influence of keloid-derived
keratinocytes on fibroblasts growth and proliferation in vitro. Plast Reconstr Surg 107:797808
Lee TY, Okochi H, Kim WJ (2004) Expression of transforming growth factor beta 1, 2, and
3 protein keloid s. Ann Plast Surg 43:179-184
Shaffer JJ, Taylor SC, Bodden F. Keloid scars: a review with a critical look at therapeutic
options. J Am Acad Dermatol. 2002:46(suppl):S63-S97
Atiyeh BS, Costagliola and Hayek (2005) Nonsurgical management of hypertropic scars:
evidence-base therapies, standart practices, and emerging methods. Aesthetic. Plast.Surg.
31:468-494
Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg. 1990: 43:70-77
Rockwell WB, Cohen IK, Ehrlich HP. Keloid and hypertropic scars: a comprehensive
review. Plast Reconstr Surg. 1989:84:827-837
Universitas Sumatera Utara
Moustafa, MF, Abdel-fattah, MA & Abdel-fattah, DC 1975,”Presumptive evidence of the
effect of pregnancy estrogens on keloid growth”, case report : Plast Reconstr Surg, vol. 56,
pp. 450-453
Mast, BA 1992,”Wound healing : Biochemical and clinical aspect in the skin”,ed IK cohen, B
Diegelmann & WJ and Lindblad WB, Saunder Company, Philadelphia,pp. 344
Nemeth, AJ 1993,”Keloid and hypertropic scars”, J Dermatol Surg Oncol, vol. 19, no. 8, pp.
738-746
Prockop, DJ & Kivirikko, KI 1995,”Collagens : molecular biology, disease, and potentials
for therapy”, Ann Rev Biochem, vol.64. pp. 403-434
Raghaw, R 1994,”The role of etracellular matrix in post imflammatory wound healing and
fibrosis”, FASEB J, vol. 8, no. 11, pp. 823-831
Santoro, MM & Gaudino, G 2005,”Cellular and molecular facets of keratinocytte
reepithelizzation during wound healing”, Exp Cell Res, vol. 304, no. 1, pp. 274-286
Schierle, HP, Scholz, D & Lemperle, G 1997,”Elevated levels of testosteron reseptors in
keloid tissue: an experimental investigation”, Plast Recontr Surg, vol.100, no. 2, pp. 390-395,
discussion 396
Sukla, IM, Arora, NP & Arora, MM 1975,”Corneal keloid”, Indian J Opthalmol, vol. 23,n0.
2, pp. 18-19
Slemp, AE & Kirsner, RE 2006,”Keloid and scars : a review of keloid and scars, their
patthogenesis, risk factors, and management”, Curr Opin Pediatr, vol. 18, no. 4, pp. 396-402
Stadelmann, WK, Digenis, AG & Tobin, GR 1998,”Physiology and healing dynamics of
chronic cuttaneus wound”, Am J Surg, vol. 176, no. 2A Suppl, pp. 26S-28S
Universitas Sumatera Utara
Sylvia, CJ 2003,”The role of neutrophil apoptosis in influencing tissue repair”, J Wound Care
, vol.12, no.1, pp. 13-16
Werner, S & Grose, R 2003,”Regulation of wound healing by growth factors and cytokine”,
Physiol Rev,vol. 83, no. 3, pp. 835-870
Urioste, SS, Arndt, KA & Dover, JS 1999,”Keloids and hypertropic scars : revieww and
treatment strategies”, Semin Cutan Med Surg, vol. 211, no. 2, pp. 159-171
Ong, CT, Khoo, YT, Tan, EK 2007,”Epithelial - mesenchimal interactions in keloid
pathogenesis modulate vascular endothelial growth factors expression and secretion”, J
Pathol, vol. 211, no. 1, pp. 95-108
Louw, L 2007,”The keloid phenomenon : progres toward a solution”, Clin Anat, vol.20, no.
1,, pp. 3-14
Knigton, DR, Hunt, TK 1983,”Oxygen tension regulated the expression of angiogenesis
factors by macrophages”, Science, vol. 221, no. 4617, pp. 1283-1285
Hinz, B 2006,”Masters and servants of the force : the role of matrix adhesions in
myofibroblast force perception and transmission’’, Eur J Cell Biol, vol. 9, no. 3-4, pp. 175181
Ford, LC, King, DF, Lagasse, LD & Newcomer, V 1983,”Increased androgen binding in
keloids : a preliminary communication”, J Dermatol Surg Oncol, vol. 9, no. 7, pp. 545-547
Cheng, JC, Evans, JH, Leung, KS 1984,”Pressure therapy in the treatment of post burn
hypertrophic scars”, Burn Ince Therm Inj. vol. 10, no. 3, pp. 154-163
Bloom, D 1956,”Heredity of keloids : review of the literature and report of a family with
multiple keloids in five generation”, N Y State J Med,vol.56, no. 4, pp. 511-519
Apfelberg, DB, Maser, MR, White, DN & Lash, H 1989,”Failure of carbon dioxide laser
excission of keloids”, Laser Surg Med, vol. 9, no. 4, pp. 382-388
Universitas Sumatera Utara
Appleton, I, Brown, NJ & Willoghby, DA 1996,”Apoptosis, necrosis, and proliferation :
possible implication in the etiology of keloids”, Am J Pathol, vol. 149, no. 5, pp. 1441-1447
Toure, Abas M. Is There an Association between Keloids and Blood Groups. Available in:
ISRDN Dermatology Vol 2012. 2012
Hilmer MP, Macleod SM, 2002. Experimental
keloid
scar
models: A review of
methodological issues journal. Journal of Cutaneous Medicine and Surgery 6(4).
Perdanakusuma D, Gayatri K. P. 2009. The relationship between blood type and the
formation of keloid post wound. Departemen / SMF Ilmu Bedah Plastik Fakultas Kedokteran
Universitas Airlangga, RSUD Dr. Soetomo, Surabaya.
Kischer CW, 1982. Fibronectin (FN) in hypertrophic scars and keloid. Cell and Tissue
Research 23 1(I): 29-37.
Savage K, Swann DA, 1985. A comparison of glycosaminoglycan synthesis by human
fibroblasts from normal skin, normal scar, and hypertropic scar. Journal Invest Dermatology
34(6) : 521-6.
Wolfram D,
Alexandar T.
Hypertrophic Scars and Keloids – A review of Their
Pathophysiology, Risk Factors, and Therapeutic Management. Available in: Dermatol Surg
2009; 35. 2009; 171-181
Ajab K., Shahzad M, Haroon T S. Keloids: Clinical Features and Management Part I.
Available in: Journal of Pakistan Association of Dermatologists 2006; 16: 97-103
Melinda S, Meites E, Daane SP. Keloids: Which Treatment is best for your patient?.
Available in: The Journal of Family Practice Vol 62 No 5. 2013: 227-233
Gauglitz Gerd G. Hypertrophic Scarring and Keloids: Pathomecanisms and Current and
Emerging Treatment Strategies. Available in: Mol Med 17 (1-2). 2011: 113-125
Universitas Sumatera Utara
Al-Attar A, Mess S, Thomassen JM . Keloid Pathogenesis and Treatment. Available in:
Plastic Reconstruction Surgery 117:286. 2006: 286-300
Seifert Oliver., Mrowietz Ulrich. Keloid Scarring: bench and bedside. Available in: Arch
Dermatol Res (2009) 301:259-272
Perdanakusuma DS, Noer MS, 2006. Penanganan parut hipertrofik dan keloid. Surabaya:
Airlangga University Press, pp. 4-18
Al-Attar, A, Mess, S, Thomassen, JM, Kauffman, CL & Davison, SP
2006, 'Keloid
pathogenesis and treatment', Plast Reconstr Surg, vol. 117, no. 1, pp. 286-300.
Sudigdo,F,Sofyan,I, 2008, Dasar – dasar metodologi penelitian klinis,ed. III. Sagung seto.
Gentur,S, 2011, Petunjuk praktis ilmu bedah plastik rekonstruksi, yayasan
khasanah
kebajikan. Sagung seto.
J. J. Brown and A. Bayat , ”Genetics susceptibility to raised dermal scarring,” British Journal
of Dermatology,vol.161, no.I, pp. 8-18,2004.
B. Shih and A. Bayat, “Genetic of keloid scarring,” Archives of Dermatological
Research,vol. 302,no. 5, pp. 319-339,2014.
A.G. Marneros, J. E. C. Norris,S. Watanabe,E. Reichenberger, and B. R. Olsen, “Genome
scans provide evidence for keloid susceptibility loci on chromosomes 2q23 and 7p11,”
Journal of Investigative Dermatology,vol. 122,no. 5, pp. 1126-1132,2004.
J. A. Clark,M. L. Turner,L. Howard,H. Stanescu,R. Kleta, and J. B. Kopp,”Description of
familial keloids in five pedigrees: evidence for autosomal dominant inheritance and
phenotypic heterogeneity,” BMC Dermatology, vol. 9, article 8, 2001.
K. M. Ramakrishnan, K. P. Thomas, and C. R. Sundararajan, “Study of 1,000 patients with
keloids in South India,,” Plastic and Reconstructive Surgery, vol. 53, no. 3, pp. 276-280,
1974.
Universitas Sumatera Utara
R. S. English and P. D. Shenefelt, “Keloid and hypertrophic scars,” Dermatologic Surgery,
vol. 25, no. 8, pp. 631-638, 1999.
Ishihara H, Yoshimoto H, Fujioka M (2000)
Keloid fibroblast resist ceramide-induced
apoptosis by overexxpression of insulin-like growth factor I receptor. J Invest Dermatol 115:
10655-1071.
Sayah DN, Soo C, Shaw WW (1999) Downregulation of apoptosis-related genes in keloid
tissues. J Surg Res 87 :209-216
Ghazizadeh M (2007) Essential role of IL-6 signaling pathway in keloid pathogenesis. J
Nippon Med Sch 7:11-22
Messadi DV, Doung HS, Zhang Q (2004) Activation of NfkappaB signal pathwayys in
keloid fibroblats. Arch Dermatol Res 296:125-133
Santucci M, Borbognoni L, Reali UM (2001) Keloids and hypertrophic scars of Caucasians
show distinctive morphologic and immunophenotypic profiles. Virchowws Arch 438:457463
Niessen FB, Schalkwwijk J, Vos H (2004) Hypertrophic scar formation is associated wwith
an increased number of epidermal Langerhans cells. J Pathol 202:121-129
Tuan TL, Wu H, Huang EY (2003) Increased plasminogen activator inhibitor-1 in keloid
fibroblast may account for their elevated collagen accumulation in fibrin gel cultures. Am J
Pathol 162:1579-1585
Zhang Q, Wu Y, Ann DK
(2003) Mechanisms of hypoxic regulation of plasminogen
activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 121:1005-1012
Universitas Sumatera Utara
Wu Y, Zhang Q, Ann DK (2004) Increased vascular endothelial growth factor may account
for elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid
fibroblasts. Am J Physiol Cell Physiol 286:C905-C912
Chodon T, Sugihara T, Igawa HH (2000) Keloid-derived fibroblasts are refractory to Fasmediated apoptosis and neutralizzation of autocrine transforming growth factor-beta I can
abrogate this resiostance. Am J Pathol 157:1661-1669
Funayama E, Chodon T, Oyama (2003) Keratinocytes promote proliferation and inhibit
apoptosis of the underlying fibroblasts: an important role in tthe pathogenesis of keloid. J
Invest Dermatol 121:1326-1333
Lim IJ, Phan TT, Song C
(2001) Investigation of the influence of keloid-derived
keratinocytes on fibroblasts growth and proliferation in vitro. Plast Reconstr Surg 107:797808
Lee TY, Okochi H, Kim WJ (2004) Expression of transforming growth factor beta 1, 2, and
3 protein keloid s. Ann Plast Surg 43:179-184
Shaffer JJ, Taylor SC, Bodden F. Keloid scars: a review with a critical look at therapeutic
options. J Am Acad Dermatol. 2002:46(suppl):S63-S97
Atiyeh BS, Costagliola and Hayek (2005) Nonsurgical management of hypertropic scars:
evidence-base therapies, standart practices, and emerging methods. Aesthetic. Plast.Surg.
31:468-494
Datubo-Brown DD. Keloids: a review of the literature. Br J Plast Surg. 1990: 43:70-77
Rockwell WB, Cohen IK, Ehrlich HP. Keloid and hypertropic scars: a comprehensive
review. Plast Reconstr Surg. 1989:84:827-837
Universitas Sumatera Utara